A similar correlation was observed in 6 prostate cancer cell lines, although the data did not reach statistical significance (Fig. 4c , right panel).
← all excerpts
Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells.
1
—
—